eBay's Growth Doesn...
Health Care: Drugs
Sanofi (SNY: NYSE)
$34.23 0.13 | 0.38%
05/24/12 - 04:05 PM ET
3.10M / 3.65M
Vol / Avg. Vol:34.24 / 34.10
Open / Prev. Close:33.98 - 34.42
Today's Range:30.98 - 40.58
52 Wk Range:-6.35%
Performance YTD:TheStreet Rating:
Portfolios with SNY
- Portfolio NameUser Type
- ProWarren Buffett
- UserKAREL VON ZOETE
- UserMARIA DEL HUERTO
- ContributorHighest-Yielding Drug Stocks
- ProKen Fisher - Fisher Investm...
- ProDiscovery Capital Management
- UserMyers
- Usercheechmil
- UserK-1
- UserMy trial 2012
Latest SNY Headlines from TheStreet
- Sanofi (SNY): Today's Featured Health Care Loser 05.16.12 | 04:05 pm
- Vertex Is the Next Gilead Sciences or Alexion 05.07.12 | 11:05 am
- Sanofi Stock To Go Ex-dividend Monday (SNY) 05.04.12 | 09:05 am
- Sanofi-Aventis's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.27.12 | 05:04 pm
- Sanofi - Special Call 04.25.12 | 07:04 pm
- Keryx: Lessons From a Drug Failure 04.02.12 | 12:04 pm
- Regeneron, Amgen And The 'Hope Creation Cycle" 04.02.12 | 07:04 am
- Sanofi-aventis' Management Presents At Credit Suisse Healthcare Conference (Transcript) 03.16.12 | 11:03 am
- Sanofi's Management Presents At Cowen Group Health Care Conference (Transcript) 03.13.12 | 11:03 pm
- Talon: Assessing Marqibo's FDA Odds 03.13.12 | 10:03 am
Press Releases for SNY
- Genzyme Brochure - Business Wire 04.24.12 | 02:04 pm
- Genzyme Demonstrates Depth Of MS Pipeline At AAN With Results From Multiple Sclerosis Phase Lll Trials - Business Wire 04.20.12 | 01:04 am
- Genzyme’s Biologics Support Center Achieves LEED Gold Rating For Environmentally Responsible Design - Business Wire 04.19.12 | 08:04 am
- Genzyme And Veracyte Announce Expanded U.S. Availability Of The Afirma® Thyroid FNA Analysis For Improved Thyroid Nodule Diagnosis - Business Wire 04.16.12 | 11:04 am
- Sanofi And Regeneron Announce Regulatory And Clinical Update For ZALTRAP® (aflibercept) - PR Newswire 04.05.12 | 01:04 am
- Genzyme And Isis Announce Submission Of U.S. NDA For KYNAMRO™ (mipomersen Sodium) In Homozygous Familial Hypercholesterolemia - Business Wire 03.29.12 | 11:03 am
- KYNAMRO™ (mipomersen Sodium) Data Presented At XVI International Symposium On Atherosclerosis - Business Wire 03.29.12 | 09:03 am
- Sanofi And Regeneron Report Phase 2 Data For Potential First-in-Class Lipid-Lowering PCSK9 Antibody - PR Newswire 03.26.12 | 11:03 am
- Sanofi To Acquire Pluromed, Inc., Expanding Its Presence In Biosurgery - PR Newswire 03.16.12 | 08:03 am
- Genzyme Begins Shipping Fabrazyme From Newly Approved Framingham Manufacturing Plant - Business Wire 03.01.12 | 08:03 am
Partner Headlines for SNY
- Lilly's GLP-1 Agonist Delivers - Analyst Blog - Zacks 05.23.12 | 07:05 pm
- The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr. Reddy's Laboratories - Press Releases - Zacks 05.22.12 | 09:05 am
- Lower than Expected Loss at Osiris - Analyst Blog - Zacks 05.15.12 | 10:05 am
- 4 New Reasons To Be Bullish On Sanofi Now - Seeking Alpha 05.13.12 | 09:05 am
- Momentum Stocks On Warren Buffett's 10 High Dividend Stocks - Seeking Alpha 05.06.12 | 09:05 am
- Primer On International Investing - Part 2 - Seeking Alpha 05.05.12 | 12:05 am
- Earnings Scorecard: Bristol-Myers - Analyst Blog - Zacks 05.04.12 | 06:05 pm
- Eylea Drives Regeneron to Profit - Analyst Blog - Zacks 04.27.12 | 07:04 pm
- Eylea Drives Regeneron to Profit - Analyst Blog - Zacks 04.27.12 | 07:04 pm
- Biogen's Fampyra Launched in Canada - Analyst Blog - Zacks 04.13.12 | 06:04 pm
